MP
NBRV
MSD Partners’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-50,000
| Closed | -$27K | – | 42 |
|
|
2020
Q3 | $27K | Hold |
50,000
| – | – | 0.01% | 33 |
|
|
2020
Q2 | $34K | Hold |
50,000
| – | – | 0.01% | 27 |
|
|
2020
Q1 | $29K | Hold |
50,000
| – | – | 0.01% | 26 |
|
|
2019
Q4 | $66K | Hold |
50,000
| – | – | 0.01% | 18 |
|
|
2019
Q3 | $100K | Hold |
50,000
| – | – | 0.01% | 20 |
|
|
2019
Q2 | $122K | Hold |
50,000
| – | – | 0.01% | 22 |
|
|
2019
Q1 | $122K | Hold |
50,000
| – | – | 0.02% | 21 |
|
|
2018
Q4 | $73K | Hold |
50,000
| – | – | 0.01% | 24 |
|
|
2018
Q3 | $135K | Hold |
50,000
| – | – | 0.01% | 23 |
|
|
2018
Q2 | $174K | Hold |
50,000
| – | – | 0.01% | 27 |
|
|
2018
Q1 | $252K | Hold |
50,000
| – | – | 0.01% | 21 |
|
|
2017
Q4 | $299K | Hold |
50,000
| – | – | 0.02% | 20 |
|
|
2017
Q3 | $410K | Buy |
+50,000
| New | +$410K | 0.01% | 29 |
|